Compartir

Survivor Views Press Releases

19 de Agosto de 2026

New Survey Finds Majority of Cancer Patients and Survivors More Likely to Participate in Clinical Trials if They Received Financial Support to Offset Participation Costs

According to a new American Cancer Society Cancer Action Network (ACS CAN) survey, 89% of cancer patients and survivors say they would be more likely to participate in a clinical trial outside their local area if trial sponsors helped them organize or pay for travel and lodging to offset the extra travel. 

2 de Diciembre de 2025

Una nueva encuesta revela que casi 3 de cada 4 pacientes y sobrevivientes de cáncer que dependen del mercado de seguros para obtener una cobertura integral corren el riesgo de perder el acceso a atención médica vital si no se extienden los créditos fiscal

La Red de Acción contra el Cáncer de la Sociedad Americana del Cáncer (ACS CAN) publicó hoy los resultados de una encuesta que explora el impacto de los créditos fiscales adicionales para las primas en los pacientes y sobrevivientes de cáncer que dependen del mercado de seguros para obtener una cobertura integral.

14 de Agosto de 2025

New Study Underscores Importance of Pharmacogenomic Testing to Patients and Finds Many Aren’t Aware of the Benefits

 A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.